Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

Abstract

BackgroundOver 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea.ConclusionThe Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.

Effects of extreme meteorological factors on daily mumps cases in Hefei, China, during 2011–2016

“…Thirdly, this study did not explore the impact of individual differences in mumps infectivity and immunity, which was hard to make a definite quantification, because the mumps case in this study was obtained directly from the CDC. Finally, studies have shown that air pollution factors are also an important risk factor for respiratory infectious diseases (Valiulis et al 2019;Cohen et al 2017;Zhou et al 2015). Because relevant data were unavailable, air pollution factors were not considered in the model, which may have some adverse impact on the results.…”

Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing

“…• Validation with COnsensus-based Standards for the selection of health Measurement INstruments guidelines 20 • Found to be the most relevant app for rhinitis and asthma 21,22 • Assessment of data quality (Bedard, in preparation) • Baseline characteristics 23 • Work productivity 16 • EuroQOL (EQ-5D) and the work productivity and activity impairment allergy-specific 7 • Novel phenotypes of allergic diseases 24 • Adherence to treatment 25,26 • Novel approaches to inform the efficacy of treatment 25 • Sleep 23 • Patient's organizations and scientific societies involved • Presented during WHO, EU ministerial meetings and EU parliament meetings 12,[27][28][29] • Next-generation care pathways meeting (December 3, 2018) with the EIP on AHA, POL-LAR and GARD • Over 70 MASK papers in 16 languages • Dissemination according to the EIP on AHA 10…”

“…[62][63][64][65] Euforea organized an EU Summit in Vilnius, Lithuania (March 2018) to propose multisectoral ICPs embedding guided self-management, mHealth and air pollution in CRDs. 12 On May 3, 2019, another Euforea-led meeting (Parliament of Malta) reviewed the results of the Vilnius Declaration.…”

Prioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research — The European Strategic Forum on Allergic Diseases

“…3. Необходима трансформация систем здравоохранения с целью перехода на широкое использование мобильных устройств и беспроводных технологий самооценки и самоконтроля пациента (так называемое цифровое здравоохранение), повышение медицинской грамотности населения и включение в круг регулируемых проблем вопросов окружающей среды (загрязнение микро-и макроокружения) и условий работы/учебы пациента [32][33][34][35].…”